Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may improve prostate cancer treatment outcomes.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Six new genes linked to early hair loss were found, which also surprisingly connect to Parkinson's disease and lower fertility.

Different genes are linked to various types of hair loss.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

A new treatment for hair loss shows promise with fewer side effects.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men with lower 2nd to 4th finger ratios tend to have larger sinus volumes.

The document explains how male reproductive hormones work and affect the body.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Gene variation affects prostate issues and hair loss.